Informační systém MU
WATANABE, Yoshihiko, Germaine CORNÉLISSEN, Franz HALBERG, Larry BEATY, Jarmila SIEGELOVÁ, Kuniaki OTSUKA and Earl E. BAKKEN. HARM VS. BENEFIT FROM LOSARTAN WITH HYDROCHLOROTHIAZIDE AT DIFFERENT CIRCADIAN TIMES IN MESOR-HYPERTENSION OR CHAT. In Noninvasive methods in cardiology. Brno: NCO NZO v Brně, MU Brno, 2008, p. 149-167. první vydání. ISBN 978-80-7013-481-8.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name HARM VS. BENEFIT FROM LOSARTAN WITH HYDROCHLOROTHIAZIDE AT DIFFERENT CIRCADIAN TIMES IN MESOR-HYPERTENSION OR CHAT
Name in Czech Poškození nebo prospěch z léčby losartanem a hydrochlorothiazide v různých časech dne u pacientů s mesorovnou hypertenzí nebo hyperamplitudovou hypertenzí
Authors WATANABE, Yoshihiko, Germaine CORNÉLISSEN, Franz HALBERG, Larry BEATY, Jarmila SIEGELOVÁ, Kuniaki OTSUKA and Earl E. BAKKEN.
Edition Brno, Noninvasive methods in cardiology, p. 149-167, 19 pp. první vydání, 2008.
Publisher NCO NZO v Brně, MU Brno
Other information
Original language English
Type of outcome Chapter(s) of a specialized book
Field of Study 30200 3.2 Clinical medicine
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
Organization unit Faculty of Medicine
ISBN 978-80-7013-481-8
Keywords in English LOSARTAN;HYDROCHLOROTHIAZIDE;MESOR-HYPERTENSION ;CHAT
Tags CHAT, HYDROCHLOROTHIAZIDE, losartan, MESOR-hypertension
Changed by Changed by: Ing. Soňa Hanzelková, učo 107137. Changed: 29/4/2009 10:19.
Abstract
HARM VS. BENEFIT FROM LOSARTAN WITH HYDROCHLOROTHIAZIDE AT DIFFERENT CIRCADIAN TIMES IN MESOR-HYPERTENSION OR CHAT
Abstract (in Czech)
Poškození nebo prospěch z léčby losartanem a hydrochlorothiazide v různých časech dne u pacientů s mesorovnou hypertenzí nebo hyperamplitudovou hypertenzí
Links
MSM0021622402, plan (intention)Name: Časná diagnostika a léčba kardiovaskulárních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Early diagnostics and treatment of cardiovascular diseases
Displayed: 15/7/2024 23:42